Share on Pinterest Bariatric surgery may be better for preserving kidney function in people with diabetes and obesity than GLP-1 drugs. Image credit: Ruben Earth/Getty Images. In a new study ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases ...

Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...

In the nonsurgical group, the most common GLP-1 medications were liraglutide and ... Researchers found that bariatric surgery ...

Studies have also demonstrated their ability to improve outcomes in cardiovascular disease, reduce the risk of kidney ... GLP-1 drugs may reduce brain inflammation and improve mitochondrial ...

These ectopic receptors influence GLP-1 and GIP secretion, serotonin and dopamine secretion, blood pressure, muscle ...

The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier (the filter that protects the brain from harmful substances), experiments ...

In fact, the molecular receptors for GLP-1 are sprinkled in many places around the body. They're found in the central nervous system, the heart, blood vessels, liver, and kidney. Their presence in ...

Research highlights how GLP-1 receptor agonists may improve brain health by targeting the neurovascular unit, linking metabolic health to cognitive function. It suggests potential therapies for ...

New research reveals how GLP-1 receptor drugs, known for treating diabetes and obesity, also protect the brain’s vital ...